Article de Périodique
Introducing NIDA's New National Drug Early Warning System (2020)
Auteur(s) :
COTTLER, L. B. ;
GOLDBERGER, B. A. ;
NIXON, S. J. ;
STRILEY, C. W. ;
BARENHOLTZ, E. ;
FITZGERALD, N. D. ;
TAYLOR, S. M. ;
PALAMAR, J. J.
Année :
2020
Page(s) :
art. 108286
Langue(s) :
Anglais
Domaine :
Autres substances / Other substances ; Drogues illicites / Illicit drugs
Discipline :
EPI (Epidémiologie / Epidemiology)
Thésaurus géographique
ETATS-UNIS
Thésaurus mots-clés
EPIDEMIE
;
SURVEILLANCE EPIDEMIOLOGIQUE
;
DROGUES DE SYNTHESE
;
FENTANYL
Résumé :
Deaths from fentanyl and from psychostimulants are increasing (Kariisa et al., 2019; O’Donnell et al., 2020) and new psychoactive substances (NPS) continue to emerge (US Drug Enforcement Administration [DEA], 2020). Methods of drug administration are also rapidly changing, with record-high increases in vaping of cannabis among adolescents (Miech et al., 2019). Further, the coronavirus disease 2019 (COVID-19) appears to be associated with drug overdoses and changes in drug use behavior (Volkow, 2020). While lagged indicators, such as national estimates of drug use, are useful for monitoring patterns of drug use and associated consequences, a national system to detect dangerous trends as they emerge is needed. [Extract]
Affiliation :
Department of Epidemiology, College of Public Health and Health Professions, College of Medicine, University of Florida, USA